
ARS Pharmaceuticals Hits Day High with 7.99% Surge to $8.85
2025-11-10 17:57:49ARS Pharmaceuticals, Inc. saw a notable increase in its stock today, reaching an intraday high. Despite this uptick, the company has faced significant challenges over the past year, including substantial declines in performance metrics and rising raw material costs, contributing to ongoing financial difficulties.
Read full news article
ARS Pharmaceuticals Hits New 52-Week Low at $8.05 Amid Declining Performance
2025-11-10 17:29:25ARS Pharmaceuticals, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company reported negative financial results after a series of positive quarters, with troubling metrics such as a return on equity of -24.97% and substantial operating losses.
Read full news articleNo announcement available
Corporate Actions
No corporate action available






